Cited by 33Gut microbiota and healthPancreatitis Pathology and TreatmentGastrointestinal motility and disorders

Lactulose regulates gut microbiota dysbiosis and promotes short-chain fatty acids production in acute pancreatitis patients with intestinal dysfunction

Open access
Wang, Jinyun, Jiang, Meilan, Hu, Yang, Lei, Yupeng, Zhu, Yin, Xiong, Huifang, He, Cong·2023·Biomedicine & Pharmacotherapy

Abstract

Intestinal dysfunction is one of the common complications in the early stage of acute pancreatitis (AP), which often associates with bad outcome. Lactulose, as a prebiotic, has been widely used to improve gut health, yet its effect on AP is unclear. This was a prospective, randomized trial of moderate severe AP patients complicated with intestinal dysfunction. A total of 73 participants were randomly assigned to receive either lactulose or Chinese herb rhubarb for 1 week. The primary efficacy endpoint was the recovery of intestinal function. The serum levels of inflammatory cytokines and gut barrier indexes were examined. The fecal samples from patients before and after treatment were collected. 16 S rRNA gene sequencing analysis was performed to explore the composition of gut microbiota and the amount of short-chain fatty acids (SCFAs) were detected by gas chromatography-mass spectrometry (GC-MS). The intestinal dysfunction was prominently improved after 7 days of treatment with either lactulose or rhubarb. The serum levels of cytokines and gut permeability index were decreased after treatment, with stronger down-regulated degree in lactulose group than rhubarb. The potential beneficial genus Bifidobacterium was enriched in lactulose group, while pathogenic bacteria including Escherichia-Shigella and Neisseria were abundant in rhubarb group. Of note, the level of SCFAs was remarkably increased after treatment, with higher amount in lactulose group than rhubarb group. Lactulose could not only restore intestinal function but also regulate gut microbiota and promote the production of SCFAs.

Integrity signals

Registry

Crossref · 10.1016/j.biopha.2023.114769

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Intestinal barrier dysfunction is an early severe complication in AP, leading to multi-organ infections and worsening disease progression.

    “Intestinal barrier dysfunction is widely acknowledged as an early severe complication in AP, leading to multi-organ infections and worsening disease progression (Agarwal et al. 2023; Wang et al. 2023).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wang, J., Jiang, M., Hu, Y., Lei, Y., Zhu, Y., Xiong, H., & He, C.
Affiliations
First Affiliated Hospital of Nanchang University (CN)
Corresponding author
  • Xiong, Huifang
  • He, Cong
Venue
Biomedicine & Pharmacotherapy
Publisher
Elsevier BV
Published
2023-07
Volume
163
Issue
1
Pages
114769
ISSN
0753-3322 (ISSN-L)
OpenAlex
W4367047375
Cited by
33
References
30
Citations by year
2026: 13 · 2025: 8 · 2024: 7 · 2023: 5
FWCI
2.93
Type
journal article
Language
en
Open access
Locations
  • Biomedicine & Pharmacotherapy (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Natural Science Foundation of China (82260133)
  • Key Research and Development Program of Jiangxi Province (20202BABL216007, 20204BCJL23048)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
lactulose, acute pancreatitis, intestinal dysfunction, gut dysbiosis, short-chain fatty acids, prebiotics, rhubarb, Bifidobacterium, intestinal permeability, inflammatory cytokines, Escherichia-Shigella, Neisseria
MeSH terms
Gastrointestinal Microbiome, Acute Disease, Fatty Acids, Volatile, Humans, Intestinal Diseases, Lactulose, Pancreatitis, Prospective Studies, Cytokines, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review